Sandercock Colin
SEC insider (Form 3/4/5 filer). CIK 0001724870. SVP, GENERAL COUNSEL at Cue Biopharma, Inc. (CUE). 4 reported Form 4/5 transactions since Sep 2024; latest on Apr 9, 2026. Located in BOSTON, MA.
Companies Sandercock Colin has filed insider reports for
- Cue Biopharma, Inc. (CUE): Officer, SVP, GENERAL COUNSEL
Sandercock Colin
CIK: 0001724870
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cue Biopharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 9, 2026CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
200K shares- - Dec 3, 2025CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
70K shares- - Sep 26, 2025CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
30K shares- - Mar 21, 2025CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 9, 2026 | CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 200,000 | - | - | Direct |
| Dec 3, 2025 | CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 70,000 | - | - | Direct |
| Sep 26, 2025 | CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Mar 21, 2025 | CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 200,000 | - | - | Direct |
1-4 of 4 transactions